HER2-positive Solid Tumor

Explore clinical trials studying HER2-positive Solid Tumor. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HER2-positive Solid Tumor trial results

Recruiting

NCT05523947

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +12 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States

Southern Oncology Clinical Research Unit Adelaide, Australia

Austin Health Melbourne, Australia

View all 19 locations

Completed

NCT03330561

Conditions: HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

University of California Los Angeles (UCLA) Santa Monica, California, United States

Georgetown University, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

Johns Hopkins University School of Medicine Baltimore, Maryland, United States

Completed

NCT03650348

Conditions: HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

UCLA Health Santa Monica, California, United States

Ochsner Cancer Institute New Orleans, Louisiana, United States